{"id":348,"date":"2021-10-15T14:02:01","date_gmt":"2021-10-15T14:02:01","guid":{"rendered":"https:\/\/libertatisergo.com\/?p=348"},"modified":"2022-02-15T15:32:08","modified_gmt":"2022-02-15T15:32:08","slug":"newsitem-6","status":"publish","type":"post","link":"https:\/\/libertatisergo.com\/newsitem-6\/","title":{"rendered":"Bimini Biotech"},"content":{"rendered":"
[et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” disabled_on=”off|off|off” _builder_version=”4.14.7″ _module_preset=”default” min_height=”120px” custom_margin=”-4%||||false|false” custom_margin_tablet=”||||false|false” custom_margin_phone=”-60px||-20px||false|false” custom_margin_last_edited=”on|tablet” custom_padding=”5px||5px|30px|true|false” custom_padding_tablet=”0px||0px|30px|true|false” custom_padding_phone=”5px|30px|5px|30px|true|true” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.14.7″ _module_preset=”default” width=”100%” custom_padding=”||0px|||” custom_css_main_element=”display: flex;” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/libertatisergo.com\/wp-content\/uploads\/2022\/01\/Logo-1.png” title_text=”Logo” url=”\/home” _builder_version=”4.14.7″ _module_preset=”default” width=”60%” width_tablet=”50%” width_phone=”100%” width_last_edited=”on|tablet” module_alignment=”left” custom_margin=”||||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.14.7″ _module_preset=”default” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_menu menu_id=”3″ submenu_direction=”downwards” active_link_color=”#001158″ dropdown_menu_line_color=”#001158″ dropdown_menu_text_color=”#001158″ active_link_color_tablet=”#001158″ active_link_color_phone=”#001158″ active_link_color_last_edited=”on|tablet” _builder_version=”4.14.7″ _module_preset=”default” menu_text_color=”#001158″ menu_font_size=”16px” text_orientation=”right” custom_margin=”||||false|false” custom_padding=”15px||||false|false” custom_padding_tablet=”0px|25px|||false|false” custom_padding_phone=”|0px|||false|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}”][\/et_pb_menu][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.14.7″ _module_preset=”default” background_color=”#001158″ custom_padding=”2%||2%||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.14.7″ _module_preset=”default” header_text_color=”#FFFFFF” header_font_size=”45px” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.14.7″ _module_preset=”default” background_color=”#d9dce6″ custom_padding=”2%||2%||false|false” global_colors_info=”{}”][et_pb_row column_structure=”3_5,2_5″ _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”3_5″ _builder_version=”4.14.7″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.14.7″ _module_preset=”default” header_text_color=”#001158″ header_font_size=”45px” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=”4.14.7″ _module_preset=”default” text_text_color=”#001158″ global_colors_info=”{}”]<\/p>\n
\u00a0Leiden, 15 October 2021 \u2013 LEH invests \u20ac250,000 into BIMINI Biotech, an innovative therapeutics start-up that develops new cancer drugs. BIMINI Biotech will leverage the funds to initiate a research program together with The Leiden Academic Centre for Drug Research (LACDR). BIMINI\u2019s technology is based on pioneering research by Professor Ger Strous at UMC Utrecht and has shown promising results in the preclinical phase. The company leverages the growth hormone receptor (GHR) via a unique mode-of-action to inhibit cancer cell growth. BIMINI moved to Leiden in 2020 to continue preclinical research.<\/span><\/p>\n